ArticleAnnals of hematology2024
Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study.
Naokazu Nakamura et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papertrialcites it